IRONWOOD PHARMACEUTICALS INCIRWD

Market cap
$705.94M
P/E ratio
Dec 31,
2011
Dec 31,
2012
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Cash and cash equivalents8713775742615412617317736362065692
Accounts receivable, net00103132111122114115129
Prepaid expenses and other current assets38611697111199812
Restricted cash-------11211-
Convertible note hedges----------1--
Total current assets168184229290500380312266307496745781233
Total current assets168184229290500380312266307496745781233
Restricted Cash, Noncurrent-------61111-
Accounts receivable, net of current portion--------33232415-
Property and equipment, net3438373021211717129866
Operating lease right-of-use assets--------1817151413
Deferred tax assets----------333284212
Intangible assets, net------------4
Other assets0046311001114
Deferred tax assets----------333284212
Total assets2092302793346197106063324035591,1271,101471
Other assets0046311001114
Total assets2092302793346197106063324035591,1271,101471
Accounts payable6141010918161841108
Accrued research and development costs763447783216521
Accrued expenses and other current liabilities----233838453026241744
Operating Lease, Liability, Current--------13333
Convertible Debt, Current----------117-200
Note hedge warrants----------10-
Total current liabilities65554161769166120413216226276
Convertible Debt, Noncurrent-------266408430337396198
Operating Lease, Liability, Noncurrent--------2220181715
Other liabilities-12-108531241028
Revolving credit facility------------300
Other liabilities-12-108531241028
Common Stock, Value, Issued--------00000
Additional paid-in capital5426498161,0561,2051,2581,3191,3951,4791,5291,5431,3491,355
Accumulated deficit-432-505-778-967-1,110-1,192-1,309-1,591-1,600-1,500-938-696-1,699
Total stockholders' equity (deficit)1101443889956710-196-9363606652-346
Accumulated other comprehensive loss000-0-0-0-0------3
Total stockholders' equity (deficit)1101443889956710-196-9363606652-346
Total liabilities and stockholders' equity2092302793346197106063324035591,1271,101471
Common Stock, Value, Issued--------00000
Additional paid-in capital5426498161,0561,2051,2581,3191,3951,4791,5291,5431,3491,355
Accumulated deficit-432-505-778-967-1,110-1,192-1,309-1,591-1,600-1,500-938-696-1,699
Total stockholders' equity (deficit)1101443889956710-196-9363606652-346
Accumulated other comprehensive loss000-0-0-0-0------3
Total stockholders' equity (deficit)1101443889956710-196-9363606652-346
Total liabilities and stockholders' equity2092302793346197106063324035591,1271,101471